Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets
Owais Gul,1 Saqib Gul2 1Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan; 2Department of Medicine, Hamdard University, Karachi, PakistanWe read with great interest, the recently published article “Risk factors for developing dementia in type...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/letter-risk-factors-for-developing-dementia-in-type-2-diabetes-me-peer-reviewed-article-NDT |
id |
doaj-04569ffa7c0742ec86d985ca399d2786 |
---|---|
record_format |
Article |
spelling |
doaj-04569ffa7c0742ec86d985ca399d27862020-11-24T22:26:08ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212019-02-01Volume 1540340443891Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targetsGul OGul SOwais Gul,1 Saqib Gul2 1Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan; 2Department of Medicine, Hamdard University, Karachi, PakistanWe read with great interest, the recently published article “Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment” by Albai et al.1 The article provided a great insight into evaluating the prevalence of mild cognitive impairment (MCI) in patients with type 2 diabetes (T2DM) and highlighted the risk factors for conversion of MCI to dementia. We would like to add some knowledge of the mechanisms and pathogenesis of the development of MCI in T2DM patients and a guide to possible future therapeutic developments.View the original paper by Albai and colleagues.https://www.dovepress.com/letter-risk-factors-for-developing-dementia-in-type-2-diabetes-me-peer-reviewed-article-NDTmild cognitive impairment (MCI)type 2 diabetes mellitus (T2DM)Dipeptidyl-4 peptidase (DPP4) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gul O Gul S |
spellingShingle |
Gul O Gul S Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets Neuropsychiatric Disease and Treatment mild cognitive impairment (MCI) type 2 diabetes mellitus (T2DM) Dipeptidyl-4 peptidase (DPP4) |
author_facet |
Gul O Gul S |
author_sort |
Gul O |
title |
Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets |
title_short |
Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets |
title_full |
Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets |
title_fullStr |
Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets |
title_full_unstemmed |
Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets |
title_sort |
mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of dpp4 activity and future possible therapeutic targets |
publisher |
Dove Medical Press |
series |
Neuropsychiatric Disease and Treatment |
issn |
1178-2021 |
publishDate |
2019-02-01 |
description |
Owais Gul,1 Saqib Gul2 1Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan; 2Department of Medicine, Hamdard University, Karachi, PakistanWe read with great interest, the recently published article “Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment” by Albai et al.1 The article provided a great insight into evaluating the prevalence of mild cognitive impairment (MCI) in patients with type 2 diabetes (T2DM) and highlighted the risk factors for conversion of MCI to dementia. We would like to add some knowledge of the mechanisms and pathogenesis of the development of MCI in T2DM patients and a guide to possible future therapeutic developments.View the original paper by Albai and colleagues. |
topic |
mild cognitive impairment (MCI) type 2 diabetes mellitus (T2DM) Dipeptidyl-4 peptidase (DPP4) |
url |
https://www.dovepress.com/letter-risk-factors-for-developing-dementia-in-type-2-diabetes-me-peer-reviewed-article-NDT |
work_keys_str_mv |
AT gulo mildcognitivedeclineintype2diabetesmellituspatientsndashriskfactorsandpathogenesisroleofdpp4activityandfuturepossibletherapeutictargets AT guls mildcognitivedeclineintype2diabetesmellituspatientsndashriskfactorsandpathogenesisroleofdpp4activityandfuturepossibletherapeutictargets |
_version_ |
1725754484375683072 |